2025 Scientific Sessions

Lunch Program: Targeting Inflammation in Atherosclerotic Disease—The New Frontier (CME)

The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.​

SCAI designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.​

ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.​

Acknowledgement of Commerical Support

This activity is supported by an unrestricted educational grant from Novo Nordisk.

Welcome and CME Information
Jennifer A Rymer, MD, MBA, MHS, Duke University Hospital, Chapel Hill, NC
The History and Mechanism of Anti-Inflammatory Agents in the Treatment of ASCVD
Joshua Beckman, MD, MSc, The University of Texas Southwestern Medical Center, Dallas, TX
Discussion (Use Discussion Slide)
Binita Shah, M.D., M.S., FSCAI, NYU Grossman School of Medicine, New York, NY
Novel Therapies for Targeting Inflammation in ASCVD
Jennifer A Rymer, MD, MBA, MHS, Duke University Hospital, Chapel Hill, NC
Wrap Up and Closing Poll
Jennifer A Rymer, MD, MBA, MHS, Duke University Hospital, Chapel Hill, NC